1. Home
  2. SCLX vs KULR Comparison

SCLX vs KULR Comparison

Compare SCLX & KULR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$14.09

Market Cap

139.3M

Sector

Health Care

ML Signal

HOLD

Logo KULR Technology Group Inc.

KULR

KULR Technology Group Inc.

HOLD

Current Price

$3.44

Market Cap

163.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
KULR
Founded
2011
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
139.3M
163.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLX
KULR
Price
$14.09
$3.44
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
N/A
$40.00
AVG Volume (30 Days)
71.9K
1.9M
Earning Date
11-14-2025
11-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,360,000.00
$16,677,036.00
Revenue This Year
N/A
$64.40
Revenue Next Year
$749.70
$105.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
71.92
52 Week Low
$3.60
$2.15
52 Week High
$34.27
$43.92

Technical Indicators

Market Signals
Indicator
SCLX
KULR
Relative Strength Index (RSI) 36.11 50.21
Support Level $12.87 $2.96
Resistance Level $20.62 $3.66
Average True Range (ATR) 1.04 0.35
MACD -0.37 0.01
Stochastic Oscillator 18.54 33.54

Price Performance

Historical Comparison
SCLX
KULR

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About KULR KULR Technology Group Inc.

KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems, artificial intelligence and Cloud computing, energy storage, 5G communication technologies, and other consumer and industrial devices.

Share on Social Networks: